logo for INBS

INBS • NASDAQ

Intelligent Bio Solutions Inc.

$17.92

+ Add to Watchlist

Stock Details

Market Cap 11,571,858
Day Change 3.61 (25.23%)
Volume 1,675,870
Avg Volume 2,226,233
Price Range 4.03-27.5

Overview

Country US
Sector Healthcare
Industry Medical - Diagnostics & Research
Exchange NASDAQ

Company Profile

Intelligent Bio Solutions Inc., a life sciences company, developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. It offers Saliva Glucose Biosensor, an organic thin-film transistor for diabetes management that measures glucose in saliva. The company also focuses on developing SARS-CoV-2 Biosensor, a biosensor test can be used as a complement to the (RNA) virus detection test; and a biosensor platform comprising of biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. The company was incorporated in 2016 and is headquartered in New York, New York. Intelligent Bio Solutions Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.

Financial Overview

52 Week High 19
52 Week High Date 2026-01-09
52 Week Low 0.538
52 Week Low Date 2025-12-15
10D Avg Trading Vol 13.68229
YTD Price Return Daily 88.0378
MTD Price Return Daily 88.0378

Cash Flow

TTM/Share -7.56799
Annual/Share -13.531
Quarterly/Share -11.4736

Price-to-Earnings

Annual Ratio 0.7734
Quarterly Ratio 0.8859
TTM

Revenue

3Y Growth 91.13
5Y Growth 74.49
Annual/Share 27.46
TTM/Share 3.8517
5Y Share Growth 1.72

Earnings Per Share

Annual -20.0408
3Y Growth
5Y Growth
Quarterly YOY Growth

Price-to-Book

Ratio 4.7483
Annual Ratio 3.967
TTM 2.5568